WINTON GROUP Ltd acquired a new stake in shares of Oscar Health, Inc. (NYSE:OSCR – Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 146,030 shares of the company’s stock, valued at approximately $2,098,000.
Other large investors have also added to or reduced their stakes in the company. Jones Financial Companies Lllp raised its stake in Oscar Health by 7,473.3% during the first quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock valued at $30,000 after buying an additional 2,242 shares during the last quarter. Strs Ohio purchased a new position in Oscar Health during the first quarter valued at $30,000. Fifth Third Bancorp raised its stake in Oscar Health by 148.7% during the fourth quarter. Fifth Third Bancorp now owns 2,363 shares of the company’s stock valued at $34,000 after buying an additional 1,413 shares during the last quarter. Quarry LP raised its stake in Oscar Health by 439.8% during the third quarter. Quarry LP now owns 1,803 shares of the company’s stock valued at $34,000 after buying an additional 1,469 shares during the last quarter. Finally, Binnacle Investments Inc purchased a new position in Oscar Health during the second quarter valued at $75,000. Hedge funds and other institutional investors own 75.70% of the company’s stock.
Oscar Health Stock Up 0.3%
OSCR stock opened at $24.59 on Monday. Oscar Health, Inc. has a 1-year low of $10.69 and a 1-year high of $25.58. The business has a fifty day moving average price of $18.39 and a 200-day moving average price of $16.07. The company has a debt-to-equity ratio of 0.26, a current ratio of 1.11 and a quick ratio of 1.11. The stock has a market capitalization of $7.41 billion, a P/E ratio of -41.68, a P/E/G ratio of 1.71 and a beta of 2.37.
Insider Transactions at Oscar Health
In other Oscar Health news, CEO Mark T. Bertolini purchased 1,000,000 shares of the firm’s stock in a transaction dated Monday, April 6th. The stock was purchased at an average price of $11.92 per share, for a total transaction of $11,920,000.00. Following the completion of the purchase, the chief executive officer directly owned 10,196,876 shares of the company’s stock, valued at $121,546,761.92. This trade represents a 10.87% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, insider Janet Liang sold 12,475 shares of the business’s stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $21.94, for a total value of $273,701.50. Following the completion of the transaction, the insider owned 259,057 shares of the company’s stock, valued at $5,683,710.58. This represents a 4.59% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last ninety days, insiders have sold 189,660 shares of company stock valued at $4,283,140. Insiders own 25.11% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of brokerages have issued reports on OSCR. Wolfe Research began coverage on Oscar Health in a research note on Tuesday, May 5th. They set a “peer perform” rating for the company. Wall Street Zen cut Oscar Health from a “strong-buy” rating to a “buy” rating in a research note on Saturday. Robert W. Baird lifted their price objective on Oscar Health from $15.00 to $19.00 and gave the company a “neutral” rating in a research note on Thursday, May 7th. Wells Fargo & Company set a $20.00 price objective on Oscar Health and gave the company an “equal weight” rating in a research note on Thursday. Finally, UBS Group lifted their price objective on Oscar Health from $15.00 to $20.00 and gave the company a “neutral” rating in a research note on Thursday, May 7th. One equities research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $20.22.
Get Our Latest Stock Analysis on OSCR
More Oscar Health News
Here are the key news stories impacting Oscar Health this week:
- Positive Sentiment: Wells Fargo upgraded Oscar Health from “strong sell” to “hold”, easing bearish sentiment even though its $20 target remains below the current share price. Zacks.com
- Positive Sentiment: Oscar Health’s recent earnings showed a major EPS beat, which supports the stock’s fundamental story despite revenue coming in below estimates.
- Neutral Sentiment: A company co-founder shifting into an advisory leadership role looks like an internal reorganization rather than a disruptive change. Oscar Health Co-Founder Shifts to Advisory Leadership Role
- Neutral Sentiment: Multiple insiders, including CFO Richard Scott Blackley and CAO Victoria Baltrus, sold shares under pre-planned 10b5-1 programs to cover tax obligations on vested equity awards, which is less concerning than discretionary selling.
- Negative Sentiment: Director Mario Schlosser sold 34,120 shares, the largest insider sale in the latest batch, which may pressure sentiment even though it was pre-arranged.
Oscar Health Company Profile
Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.
The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.
Featured Articles
- Five stocks we like better than Oscar Health
- These 3 Insurance Stocks Made New 52-Week Highs: Still Time to Buy?
- 3 Stocks Under $20 to Buy Before a Broader Market Rally
- Petco Faces Tough Competition, But Momentum Is Building
- The Lock-In Effect Is Real—These 3 Homebuilders Are Betting on It
Want to see what other hedge funds are holding OSCR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oscar Health, Inc. (NYSE:OSCR – Free Report).
Receive News & Ratings for Oscar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oscar Health and related companies with MarketBeat.com's FREE daily email newsletter.
